Parkinson's disease: towards better preclinical models and personalized treatments.

about

ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease.

P2860

Q41348875-6B971F26-74B8-4A40-819A-741EA1FCB0F7

P2860

Parkinson's disease: towards better preclinical models and personalized treatments.

Item

http://www.wikidata.org/entity/Q50536122

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Parkinson's disease: towards better preclinical models and personalized treatments.

@en

Parkinson's disease: towards better preclinical models and personalized treatments.

@nl

type

Item

label

Parkinson's disease: towards better preclinical models and personalized treatments.

@en

Parkinson's disease: towards better preclinical models and personalized treatments.

@nl

prefLabel

Parkinson's disease: towards better preclinical models and personalized treatments.

@en

Parkinson's disease: towards better preclinical models and personalized treatments.

@nl

P1476

Parkinson's disease: towards better preclinical models and personalized treatments.

@en

P2093

Dan Lindholm

http://www.w3.org/2001/XMLSchema#string

Giuseppa Mudò

http://www.w3.org/2001/XMLSchema#string

Johanna Mäkelä

http://www.w3.org/2001/XMLSchema#string

Mart Saarma

http://www.w3.org/2001/XMLSchema#string

Natale Belluardo

http://www.w3.org/2001/XMLSchema#string

Ove Eriksson

http://www.w3.org/2001/XMLSchema#string

P2860

GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function

GDNF family receptor complexes are emerging drug targets

Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein

Disease-modifying strategies for Parkinson's disease.

Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons

Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model

Genitourinary dysfunction in Parkinson's disease.

Repairing the parkinsonian brain with neurotrophic factors.

Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.

Current disease modifying approaches to treat Parkinson's disease.

P2888

s00018-016-2141-1

P304

1383-1385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00018-016-2141-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Valentina Di Liberto

P577

2016-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292990488

http://www.w3.org/2001/XMLSchema#string

P698

26841827

http://www.w3.org/2001/XMLSchema#string

Parkinson's disease: towards better preclinical models and personalized treatments.

about

P2860

P2860

Parkinson's disease: towards better preclinical models and personalized treatments.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698